Seeking Alpha

Prolor Biotech (PBTH) +8.3% premarket after receiving a notice of allowance from the U.S. patent...

Prolor Biotech (PBTH) +8.3% premarket after receiving a notice of allowance from the U.S. patent office for a new patent application covering its long-acting CTP-enhanced human growth hormone. The patent gives PBTH additional intellectual property protection covering methods for the induction of growth in growth hormone deficient patients.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|